NKX2-1 and acute lymphoblastic leukemia: Although it is not expressed during normal T-cell development, 5% of T-ALL samples express high NKX2–1 levels due to chromosomal translocations or genomic amplifications (referred to as NKX2–1 altered samples below) [15, 18].